PubMed

Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.

Salpeter SR, Ormiston TM, Salpeter EE.

Ann Intern Med. 2004 May 18;140(10):802-13.PMID: 15148067 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardioselective beta-blockers for reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2002;(1):CD002992. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD002992. PMID: 11869646 [PubMed - indexed for MEDLINE]Related articles

Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

Salpeter SR, Ormiston TM, Salpeter EE.

Ann Intern Med. 2002 Nov 5;137(9):715-25.PMID: 12416945 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials.

Stoodley RG, Aaron SD, Dales RE.

Ann Emerg Med. 1999 Jul;34(1):8-18.PMID: 10381989 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Tolerance to beta2-agonist treatment after regular use in people with asthma.

[No authors listed]

Ann Intern Med. 2004 May 18;140(10):I41. No abstract available. PMID: 15148090 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardioselective beta-blockers for reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2002;(4):CD002992. Review.PMID: 12519582 [PubMed - indexed for MEDLINE]Related articles

Cardioselective beta-blocker use in patients with reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2001;(2):CD002992. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002992. PMID: 11406056 [PubMed - indexed for MEDLINE]Related articles

Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.

van Schayck CP, Cloosterman SG, Bijl-Hofland ID, van den Hoogen H, Folgering HT, van Weel C.

Respir Med. 2002 Mar;96(3):155-62.PMID: 11908511 [PubMed - indexed for MEDLINE]Related articles

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.

Ni CM, Greenstone IR, Ducharme FM.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005307. Review.PMID: 15846751 [PubMed - indexed for MEDLINE]Related articles

Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma.

Newnham DM, McDevitt DG, Lipworth BJ.

Am J Med. 1994 Jul;97(1):29-37.PMID: 7913292 [PubMed - indexed for MEDLINE]Related articles

Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.

Walters EH, Walters J.

Cochrane Database Syst Rev. 2000;(4):CD001285. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD001285. PMID: 11034709 [PubMed - indexed for MEDLINE]Related articles

Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma.

van Schayck CP, Bijl-Hofland ID, Cloosterman SG, Folgering HT, van der Elshout FJ, Van Weel C.

Eur Respir J. 2002 Feb;19(2):240-5.PMID: 11871364 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137. PMID: 15674901 [PubMed - indexed for MEDLINE]Related articles

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

Salpeter SR, Ormiston TM, Salpeter EE, Poole PJ, Cates CJ.

Respir Med. 2003 Oct;97(10):1094-101.PMID: 14561016 [PubMed - indexed for MEDLINE]Related articles

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

Lancet. 2004 Oct 23-29;364(9444):1505-12.PMID: 15500895 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.

Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE.

Ann Intern Med. 2006 Jun 20;144(12):904-12. Epub 2006 Jun 5.PMID: 16754916 [PubMed - indexed for MEDLINE]Related articlesFree article

Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.

Yang WH, Martinot JB, Pohunek P, Beier J, Magula D, Cameron R, Owen R, Higgins M.

Ann Allergy Asthma Immunol. 2007 Dec;99(6):555-61.PMID: 18219838 [PubMed - indexed for MEDLINE]Related articles

Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.

Haney S, Hancox RJ.

Respir Res. 2005 Sep 16;6:107.PMID: 16168062 [PubMed - indexed for MEDLINE]Related articlesFree article

A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.

Sovani MP, Whale CI, Tattersfield AE.

Drug Saf. 2004;27(10):689-715. Review.PMID: 15350154 [PubMed - indexed for MEDLINE]Related articles

Inhaled beclomethasone versus placebo for chronic asthma.

Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD002738. Review.PMID: 15674896 [PubMed - indexed for MEDLINE]Related articles